Cooley Advises Cara Therapeutics on its Initial Public Offering
New York – February 6, 2014 – Cooley LLP announced today that it advised Cara Therapeutics, Inc. on its $55 million IPO. Cara Therapeutics, a biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation, now trades on the NASDAQ Global Stock Market under the symbol "CARA."
The Cooley corporate and securities team advising Cara was led by partner Bo Yaghmaie and included partners Darren DeStefano and Stephane Levy and associates Hosea Chang, Alexander Rea, Brandy Ellis, Steve Bielecki, Jenny Baer Tuohy, and Rachel High. Critical support for the offering was provided by partner Thomas Blinka and associate Sandhya Deo (intellectual property); partners Natasha Leskovsek and Wendy Goldstein and associate Jennifer Shanley (healthcare and life sciences regulatory); partner Dave Walsh (compensation and benefits); and partners Mike Faber and Mark Windfeld-Hansen (tax).
This offering follows Cooley's record year for capital markets work in 2013 in which the firm advised on 60 public offerings, including 23 IPOs, raising more than $8.4 billion.
About Cooley LLP
Cooley's attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law.
Cooley has more than 750 lawyers across 11 offices in the United States and China.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.